Iodoacetamide
Skeletal formula
Space-filling model
Names
Preferred IUPAC name
2-Iodoacetamide
Other names
IAA[1]
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.005.119
EC Number
  • 205-630-1
RTECS number
  • AC4200000
UNII
  • InChI=1S/C2H4INO/c3-1-2(4)5/h1H2,(H2,4,5) checkY
    Key: PGLTVOMIXTUURA-UHFFFAOYSA-N checkY
  • InChI=1/C2H4INO/c3-1-2(4)5/h1H2,(H2,4,5)
    Key: PGLTVOMIXTUURA-UHFFFAOYAE
  • C(C(=O)N)I
Properties
C2H4INO
Molar mass 184.964 g·mol−1
Appearance white crystals (yellow colouration indicates the presence of iodine)
Melting point 94 °C (201 °F; 367 K)
Hazards
NFPA 704 (fire diamond)
NFPA 704 four-colored diamond
3
0
1
Safety data sheet (SDS) MSDS 1, MSDS 2
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references

2-Iodoacetamide (IAA) is an alkylating agent used for peptide mapping purposes. Its actions are similar to those of iodoacetate. It is commonly used to bind covalently with the thiol group of cysteine so the protein cannot form disulfide bonds.[2][3] It is also used in ubiquitin studies as an inhibitor of deubiquitinase enzymes (DUBs) because it alkylates the cysteine residues at the DUB active site.

Peptidase inhibitor

Iodoacetamide is an irreversible inhibitor of all cysteine peptidases, with the mechanism of inhibition occurring from alkylation of the catalytic cysteine residue (see schematic). In comparison with its acid derivative, iodoacetate, iodoacetamide reacts substantially faster. This observation appears contradictory to standard chemical reactivity, however the presence of a favourable interaction between the positive imidazolium ion of the catalytic histidine and the negatively charged carboxyl-group of the iodoacetate is the reason for the increased relative activity of iodoacetamide.[4]

Mechanism of irreversible inhibition of cysteine peptidases with iodoacetamide.

Protein mass spectrometry

It is commonly used during the sample preparation for de novo (peptide) sequencing with protein mass spectrometry, but recent critics suggest to avoid the use of it [5]

References

  1. Krüger, Ralf; Hung, Chien-Wen; Edelson-Averbukh, Marina; Lehmann, Wolf D. (2005). "Iodoacetamide-alkylated methionine can mimic neutral loss of phosphoric acid from phosphopeptides as exemplified by nano-electrospray ionization quadrupole time-of-flight parent ion scanning". Rapid Communications in Mass Spectrometry. Wiley. 19 (12): 1709–1716. doi:10.1002/rcm.1976. ISSN 0951-4198.
  2. Smythe CV (1936). "The reactions of Iodoacetate and of Iodoacetamide with various Sulfhydryl groups, with Urease, and with Yeast preparations". J. Biol. Chem. 114 (3): 601–12. doi:10.1016/S0021-9258(18)74789-3.
  3. Anson ML (1940). "The reactions of Iodine and Iodoacetamide with native Egg Albumin". J. Gen. Physiol. 23 (3): 321–31. doi:10.1085/jgp.23.3.321. PMC 2237930. PMID 19873158.
  4. Polgar, L (1979). "Deuterium isotope effects on papain acylation. Evidence for lack of general base catalysis and for enzyme-leaving group. interaction". Eur. J. Biochem. 98 (2): 369–374. doi:10.1111/j.1432-1033.1979.tb13196.x. PMID 488108.
  5. Müller (2017). "Systematic Evaluation of Protein Reduction and Alkylation Reveals Massive Unspecific Side Effects by Iodine-containing Reagents". Molecular & Cellular Proteomics. 16 (7): 1173–1187. doi:10.1074/mcp.M116.064048. PMC 5500753. PMID 28539326.
  • The MEROPS online database for peptidases and their inhibitors:
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.